DIABIO.ST

Diagonal Bio AB (publ) [DIABIO.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

DIABIO.ST Stock Summary

In the News

DIABIO.ST Financial details

Company Rating
-
Market Cap
74.55M
Income
-11.68M
Revenue
2.75M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.82
Forward P/E
-
PEG
0.1
P/S
-
P/B
0.46
P/C
-
P/FCF
-0.91
Quick Ratio
0.7
Current Ratio
1.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.26
EPS next Y
-
EPS next Q
-
EPS this Y
-88.24%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-97.06%
EPS Q/Q
-49.35%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-44%
ROE
-53%
ROC
-0.54%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.049087-0.823
52W High
-
52W Low
-
RSI
49
Rel Volume
4.66
Avg Volume
1M
Volume
4.67M
Perf Week
3.57%
Perf Month
-12.65%
Perf Quarter
-
Perf Half Y
-63.48%
-
-
-
-
Beta
0.657
-
-
Volatility
0%, 0%
Prev Close
3.57%
Price
0.0145
Change
3.57%

Something similar

Top by Market Cap
MIX.JO
FXAIX
DHR-PB
GOOG
MSF.DE
Same Sector
0L85.L
BLFS
4151.T
MLMIB.PA
INSM
Same Price Range
FDCT
PKKFF
8221.HK
OMTK
0106.HK
Similar Market Cap
X026.DE
TAGG
JHAA
1059.HK
ALNOV.PA

Company Profile

Healthcare Biotechnology
  • Volume Average 1M
  • Market Capitalization 74.55M
  • Employee 4
  • CEO Ms. Karin Wehlin MBA
  • Headquarters Lund,SE
  • IPO Date 2021-07-16
  • Website https://diagonalbio.com

Diagonal Bio AB operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was founded in 2020 and is headquartered in Lund, Sweden.